Rakovina Therapeutics Inc's total assets for Q2 2024 were C$6.23M, an increase of 35.13% from the previous quarter. TSE:RKV total liabilities were C$2.42M for the fiscal quarter, a 45.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.